Keurig Dr Pepper earnings on deck: Innovation push in focus
📌 Key Takeaways
- {"type":"skipped","reason":"older_than_3_days"}
📚 Related People & Topics
Keurig Dr Pepper
American beverage company
Keurig Dr Pepper Inc. is a publicly traded American beverage and coffeemaker conglomerate with headquarters located in Burlington, Massachusetts, and Frisco, Texas. Formed in July 2018, with the merger of Keurig Green Mountain and Dr Pepper Snapple Group (formerly Dr Pepper/7up Inc.), Keurig Dr Pepp...
Entity Intersection Graph
Connections for Keurig Dr Pepper:
🌐
SEC
1 shared
Mentioned Entities
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Gold prices rise on Trump tariff jitters; Russia sold gold holding in January U.S. stocks fall as traders parse Trump tariff turmoil Buy the dip in stocks amid geopolitical jitters, JPM’s Matejka says Trump’s new 15% tariff raises fresh legal and trade questions (South Africa Philippines Nigeria) Keurig Dr Pepper earnings on deck: Innovation push in focus By Investing.com Earnings Published 02/23/2026, 10:54 AM Keurig Dr Pepper earnings on deck: Innovation push in focus 0 KDP 0.86% Keurig Dr Pepper Inc. is set to report fourth-quarter results before the market opens Tuesday, as investors assess whether the beverage giant’s aggressive product innovation strategy can sustain accelerating revenue growth. Analysts expect revenue to grow 7.2% year-over-year, improving from the 5.2% increase recorded in the same quarter last year. Analysts anticipate earnings of $0.59 per share on revenue of $4.36 billion, representing modest sequential improvement from the third quarter’s $0.54 per share and $4.31 billion. The consensus would mark year-over-year EPS growth of 1.5%. Estimate momentum has been mixed heading into the print. EPS estimates have remained flat over the past week but declined 0.58% over the past two months, while revenue estimates similarly held steady in recent days after drifting 0.09% lower over the past 60 days. The modest downward drift suggests some caution among analysts, though expectations have stabilized more recently. Wall Street maintains a bullish stance on the $40.1 billion company. Analysts rate the stock a Buy, with a mean price target of $34.43 implying 16.5% upside from the current $29.54 share price. Ten of 16 analysts covering the stock recommend buying, while six rate it a hold and none recommend selling. What Investors Are Watching Revenue growth sustainability tops the watchlist. The company is targeting 7%-plus growth, and investors will scrutinize whether execution can match expec...
Read full article at source